Search Results - "Badn, Wiaam"

The dual role of nitric oxide in glioma by Badn, Wiaam, Siesjö, Peter

“…Malignant gliomas bear the most dismal prognosis of all human cancers despite the progress in therapy of many other tumors. The search for alternative and…”
Get more information

Low-Dose Combretastatin A4 Phosphate Enhances the Immune Response of Tumor Hosts to Experimental Colon Carcinoma by BADN, Wiaam, KALLIOMAKI, Suzanne, WIDEGREN, Bengt, SJÖGREN, Hans Olov

“…Purpose: Although there is a need to enhance the therapeutic efficiency in cancer by combining immunotherapeutic procedures with other therapy, combination…”
Get full text

Recruited Brain Tumor‐Derived Mesenchymal Stem Cells Contribute to Brain Tumor Progression by Behnan, Jinan, Isakson, Pauline, Joel, Mrinal, Cilio, Corrado, Langmoen, Iver A., Vik‐Mo, Einar O., Badn, Wiaam

Get full text

Recruited Brain Tumor‐Derived Mesenchymal Stem Cells Contribute to Brain Tumor Progression by Behnan, Jinan, Isakson, Pauline, Joel, Mrinal, Cilio, Corrado, Langmoen, Iver A., Vik‐Mo, Einar O., Badn, Wiaam

“…The identity of the cells that contribute to brain tumor structure and progression remains unclear. Mesenchymal stem cells (MSCs) have recently been isolated…”
Get full text

PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients by Liu, Yawei, Carlsson, Robert, Ambjørn, Malene, Hasan, Maruf, Badn, Wiaam, Darabi, Anna, Siesjö, Peter, Issazadeh-Navikas, Shohreh

“…Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor. In general, tumor growth requires disruption of the tissue microenvironment, yet how…”
Get full text

Low Levels of CD4+CD28null T Cells at Baseline Are Associated With First-Time Coronary Events in a Prospective Population-Based Case-Control Cohort by Tomas, Lukas, Bengtsson, Eva, Andersson, Linda, Badn, Wiaam, Tengryd, Christoffer, Persson, Ana, Edsfeldt, Andreas, Nilsson, Peter M., Schiopu, Alexandru, Nilsson, Jan, Gonçalves, Isabel, Björkbacka, Harry

“…OBJECTIVE:CD4CD28 T cells have been shown to be associated with recurrent coronary events and suggested as potential biomarker and therapeutic target. It is…”
Get full text

Low Levels of CD4 + CD28 null T Cells at Baseline Are Associated With First-Time Coronary Events in a Prospective Population-Based Case-Control Cohort by Tomas, Lukas, Bengtsson, Eva, Andersson, Linda, Badn, Wiaam, Tengryd, Christoffer, Persson, Ana, Edsfeldt, Andreas, Nilsson, Peter M, Schiopu, Alexandru, Nilsson, Jan, Gonçalves, Isabel, Björkbacka, Harry

“…CD4 CD28 T cells have been shown to be associated with recurrent coronary events and suggested as potential biomarker and therapeutic target. It is unknown…”
Get full text

Invariant natural killer T cells and incidence of first-time coronary events: a nested case-control study by Tomas, Lukas, Katra, Pernilla, Badn, Wiaam, Andersson, Linda, Nilsson, Jan, Schiopu, Alexandru, Engelbertsen, Daniel, Goncalves, Isabel, Bengtsson, Eva, Bjorkbacka, Harry

“…Abstract Aims Invariant natural killer T (iNKT) cells, a T cell subset that is CD1d-restricted and expresses a semi-invariant T cell receptor, have been…”
Get full text

Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors by Eberstål, Sofia, Badn, Wiaam, Fritzell, Sara, Esbjörnsson, Magnus, Darabi, Anna, Visse, Edward, Siesjö, Peter

“…Glioblastoma multiforme is the most common and aggressive malignant brain tumor in humans, and the prognosis is very poor despite conventional therapy…”
Get full text

Cure of established GL261 mouse gliomas after combined immunotherapy with GM‐CSF and IFNγ is mediated by both CD8+ and CD4+ T‐cells by Smith, Karin Enell, Fritzell, Sara, Badn, Wiaam, Eberstål, Sofia, Janelidze, Shorena, Visse, Edward, Darabi, Anna, Siesjö, Peter

“…We were the first to demonstrate that combined immunotherapy with GM‐CSF producing GL261 cells and recombinant IFNγ of preestablished GL261 gliomas could cure…”
Get full text

Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors by Badn, Wiaam, Visse, Edward, Darabi, Anna, Smith, Karin Enell, Salford, Leif G, Siesjö, Peter

“…High-grade gliomas are one of the most aggressive human tumors with <1% of patients surviving 5 years after surgery. Immunotherapy could offer a possibility to…”
Get full text

Synergism between GM–CSF and IFNγ: Enhanced immunotherapy in mice with glioma by Smith, Karin E., Janelidze, Shorena, Visse, Edward, Badn, Wiaam, Salford, Leif, Siesjö, Peter, Darabi, Anna

“…Glioblastoma multiforme is the most common malignant primary brain tumor and also one of the most therapy‐resistant tumors. Because of the dismal prognosis,…”
Get full text

Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells by Smith, Karin Enell, Fritzell, Sara, Badn, Wiaam, Eberstål, Sofia, Janelidze, Shorena, Visse, Edward, Darabi, Anna, Siesjö, Peter

“…We were the first to demonstrate that combined immunotherapy with GM-CSF producing GL261 cells and recombinant IFNgamma of preestablished GL261 gliomas could…”
Get full text

Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNy is mediated by both CD8+ and CD4+ T-cells by SMITH, Karin Enell, FRITZELL, Sara, BADN, Wiaam, EBERSTAL, Sofia, JANELIDZE, Shorena, VISSE, Edward, DARABI, Anna, SIESJÖ, Peter

Get full text

Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma by Smith, Karin E, Janelidze, Shorena, Visse, Edward, Badn, Wiaam, Salford, Leif, Siesjö, Peter, Darabi, Anna

“…Glioblastoma multiforme is the most common malignant primary brain tumor and also one of the most therapy-resistant tumors. Because of the dismal prognosis,…”
Get full text

Immunizations With IFNγ Secreting Tumor Cells can Eliminate Fully Established and Invasive Rat Gliomas by JANELIDZE, Shorena, BEXELL, Daniel, SIESJÖ, Peter, VISSE, Edward, BAN, Wiaam, DARABI, Anna, SMITH, Karin-Enell, FRITZELL, Sara, GUNNARSSON, Salina, MILOS, Peter, BENGZON, Johan, SALFORD, Leif Göran

“…Immunotherapy of malignant primary brain tumors holds the potential to improve the dismal prognosis after current clinical therapy. Although immunotherapy of…”
Get full text

Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas by Janelidze, Shorena, Bexell, Daniel, Badn, Wiaam, Darabi, Anna, Smith, Karin-Enell, Fritzell, Sara, Gunnarsson, Salina, Milos, Peter, Bengzon, Johan, Salford, Leif Göran, Siesjö, Peter, Visse, Edward

“…Immunotherapy of malignant primary brain tumors holds the potential to improve the dismal prognosis after current clinical therapy. Although immunotherapy of…”
Get full text

Inhibition of Inducible Nitric Oxide Synthase Enhances Anti-tumour Immune Responses in Rats Immunized with IFN-γ-Secreting Glioma Cells by Badn, W, Hegardt, P, Fellert, M.A, Darabi, A, Esbjörnsson, M, Smith, K.E, Janelidze, S, Salford, L.G, Visse, E, Siesjö, P

“…Interferon gamma (IFN-γ) has successfully been used in immunotherapy of different experimental tumours. Mechanistically, IFN-γ has extensive effects on the…”
Get full text

Postimmunization with IFN-{gamma}-Secreting Glioma Cells Combined with the Inducible Nitric Oxide Synthase Inhibitor Mercaptoethylguanidine Prolongs Survival of Rats with Intracerebral Tumors by Badn, Wiaam, Visse, Edward, Darabi, Anna, Smith, Karin Enell, Salford, Leif G, Siesjo, Peter

Get full text